Wolfson L, Watt J, Henkle E, Oria-Knoll M, McCall N. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global esimates. Lancet. 2009;374(9693):893r902.

Google Scholar 

Grimwood K, Chang AB. Long-term effects of pneumonia in young children. Pneumonia. 2015;6(1):101–14.

Article  PubMed  PubMed Central  Google Scholar 

Edmond K, Scott S, Korczak V, Ward C, Sanderson C, Theodoratou E, et al. Long term sequelae from childhood pneumonia; systematic review and meta-analysis. PLoS One. 2012;7(2):e31239-e.

Article  Google Scholar 

Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ. 2004;82:895–903.

PubMed  Google Scholar 

Liu L, Black RE. Child survival in 2015: much accomplished, but more to do. Lancet. 2015;386(10010):2234–5.

Article  PubMed  Google Scholar 

World Health Organization. Pneumonia Fact Sheet. 2019. [Available from: https://www.who.int/news-room/fact-sheets/detail/pneumonia]. Accessed 19th Apr 2021.

Google Scholar 

Dadonaite B, Roser M. Pneumonia. 2018. [Available from: https://ourworldindata.org/pneumonia]. Accessed 9th Feb 2022.

Google Scholar 

European Centre for Disease Prevention and Control. Factsheet about pneumococcal disease. [Available from: https://www.ecdc.europa.eu/en/pneumococcal-disease/facts]. [Last Accessed: 9th Feb 2022]

Shiri T, Khan K, Keaney K, Mukherjee G, McCarthy ND, Petrou S. Pneumococcal disease: a systematic review of health utilities, resource use, costs, and economic evaluations of interventions. Value in Health. 2019;22(11):1329–44.

Article  PubMed  Google Scholar 

Htar MTT, Christopoulou D, Schmitt H-J. Pneumococcal serotype evolution in Western Europe. BMC Infect Dis. 2015;15(1):419.

Article  Google Scholar 

WHO. Pneumococcal vaccines: WHO position paper—2012. Wkly Epidemiol Rec. 2012;87(14):129–44.

Google Scholar 

Suaya JA, Gessner BD, Fung S, Vuocolo S, Scaife J, Swerdlow DL, et al. Acute otitis media, antimicrobial prescriptions, and medical expenses among children in the United States during 2011–2016. Vaccine. 2018;36(49):7479–86.

Article  PubMed  Google Scholar 

Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009;302(7):758–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robert Koch-Institut. Mitteilung der Ständigen Impfkommission (STIKO) am RKI Wissenschaftliche Begründung zur Änderung der Pneumokokken-Impfempfehlung für Säuglinge. Berlin: Robert Koch-Institut; 2015.

Robert Koch-Institut. German Standing Committee on Vaccination (STIKO) vaccination recommendations 2017/18 2017 [Available from: https://www.rki.de/EN/Content/infections/Vaccination/recommandations/recommendations_node.html].

Robert Koch-Institut. Impfquoten von Kinderschutzimpfungen in Deutschland – aktuelle Ergebnisse aus der RKI-Impfsurveillance. Berlin: Epidemiologisches Bulletin 49/2021.; 2021.

Falkenhorst G, Remschmidt C, Harder T, Wichmann O, Glodny S, Hummers-Pradier E, et al. Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2016;59(12):1623–57.

Article  CAS  PubMed  Google Scholar 

Kuhlmann A, von der Schulenburg J-MG. Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany. Eur J Health Econ. 2017;18(3):273–92.

Article  PubMed  Google Scholar 

U.S. FDA Approves Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Infants and Children.  2022. [press release]

GRADE: PCV15 use in children aged 2–18 years with certain underlying medical conditions that increase the risk of pneumococcal disease. 2022. [press release].

The Medical Letter on Drugs and Therapeutics. Two New Pneumococcal Vaccines—Prevnar 20 and Vaxneuvance. JAMA. 2021;326(24):2521–2.

Article  Google Scholar 

European Commission Expands Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) Indication to Include Infants, Children and Adolescents. 2022. [press release].

European Health Observatory. Country overview: Germany. [Available from: https://eurohealthobservatory.who.int/countries/germany#:~:text=Country%20overview,around%2088%25%20of%20the%20population. Last accessed 28th Nov 2022.

Andersohn F, Walker J. Characteristics and external validity of the German Health Risk Institute (HRI) Database. Pharmacoepidemiol Drug Saf. 2016;25(1):106–9.

Article  PubMed  Google Scholar 

Goycoolea MV, Hueb MM, Ruah C. Otitis media: the pathogenesis approach. Definitions and terminology. Otolaryngol Clin North Am. 1991;24(4):757–61.

Article  CAS  PubMed  Google Scholar 

Marom T, Tan A, Wilkinson GS, Pierson KS, Freeman JL, Chonmaitree T. Trends in otitis media-related health care use in the United States, 2001–2011. JAMA Pediatr. 2014;168(1):68–75.

Article  PubMed  PubMed Central  Google Scholar 

Pelton SI, Shea KM, Farkouh RA, Strutton DR, Braun S, Jacob C, et al. Rates of pneumonia among children and adults with chronic medical conditions in Germany. BMC Infect Dis. 2015;15:470.

Article  PubMed  PubMed Central  Google Scholar 

Reimbursement Institute. Brief introduction to the G-DRG system. 2017. [Available from: https://reimbursement.institute/en/blog-en/brief-introduction-to-the-g-drg-system/. [Accessed 11th May 2021]

Google Scholar 

Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26(4):404–13.

Article  Google Scholar 

Turner HC, Lauer JA, Tran BX, Teerawattananon Y, Jit M. Adjusting for inflation and currency changes within health economic studies. Value in Health. 2019;22(9):1026–32.

Article  PubMed  Google Scholar 

Daniel M, Gautam S, Scrivener TA, Meller C, Levin B, Curotta J. What effect has pneumococcal vaccination had on acute mastoiditis? J Laryngol Otol. 2013;127(Suppl 1):S30–4.

Article  PubMed  Google Scholar 

Kordeluk S, Orgad R, Kraus M, Puterman M, Kaplan DM, Novak L, et al. Acute mastoiditis in children under 15 years of age in Southern Israel following the introduction of pneumococcal conjugate vaccines: a 4-year retrospective study (2009–2012). Int J Pediatr Otorhinolaryngol. 2014;78(10):1599–604.

Article  PubMed  Google Scholar 

Tamir SO, Roth Y, Dalal I, Goldfarb A, Marom T. Acute mastoiditis in the pneumococcal conjugate vaccine era. Clin Vaccine Immunol. 2014;21(8):1189–91.

Article  PubMed  PubMed Central  Google Scholar 

Thorne MC, Chewaproug L, Elden LM. Suppurative complications of acute otitis media: changes in frequency over time. Arch Otolaryngol Head Neck Surg. 2009;135(7):638–41.

Article  PubMed  Google Scholar 

Halgrimson WR, Chan KH, Abzug MJ, Perkins JN, Carosone-Link P, Simões EAF. Incidence of acute mastoiditis in colorado children in the pneumococcal conjugate vaccine Era. Pediatr Infect Dis J. 2014;33(5):453–7.

Article  PubMed  Google Scholar 

Hu T, Podmore B, Barnett R, Beier D, Galetzka W, Qizilbash N, et al. Incidence of acute otitis media in children < 16 years old in Germany during 2014–2019. BMC Pediatr. 2022;22(1):204.

Article  PubMed  PubMed Central  Google Scholar 

Ehlken B, Ihorst G, Lippert B, Rohwedder A, Petersen G, Schumacher M, et al. Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. Eur J Pediatr. 2005;164(10):607–15.

Article  PubMed  Google Scholar 

Wolleswinkel-van den Bosch JH, Stolk EA, Francois M, Gasparini R, Brosa M. The health care burden and societal impact of acute otitis media in seven European countries: results of an Internet survey. Vaccine. 2010;28 Suppl 6:G39-52.

Article  PubMed  Google Scholar 

Barbieri E, Cantarutti A, Porcu G, Hu T, Petigara T, Prandi GM, et al. A retrospective database analysis of burden of IPD and pneumonia in children <15y in Veneto region. Eur J Public Health. 2020;30(Supplement_5):ckaa166-1414.

Google Scholar 

Amicizia D, Astengo M, Paganino C, Piazza MF, Sticchi C, Orsi A, et al. Economic burden of pneumococcal disease in children in Liguria, Italy. Hum Vaccin Immunother. 2022;17:2082205.

Article  Google Scholar 

Fortanier AC, Venekamp RP, Stellato RK, Sanders EA, Damoiseaux RA, Hoes AW, et al. Outpatient antibiotic use in Dutch infants after 10-valent pneumococcal vaccine introduction: a time-series analysis. BMJ Open. 2018;8(6):e020619.

Article  PubMed  PubMed Central  Google Scholar 

Shiri T, McCarthy ND, Petrou S. The impact of childhood pneumococcal vaccination on hospital admissions in England: a whole population observational study. BMC Infect Dis. 2019;19(1):1–8.

Article  Google Scholar 

Chen C, Liceras FC, Flasche S, Sidharta S, Yoong J, Sundaram N, et al. Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis. Lancet Glob Health. 2019;7(1):e58–67.

Article  PubMed  Google Scholar 

WHO. WHO guide for standardization of economic evaluations of immunization programmes. Geneva: World Health Organization; 2019. https://apps.who.int/iris/bitstream/handle/10665/329389/WHO-IVB-19.10-eng.pdf.

Balsells E, Guillot L, Nair H, Kyaw MH. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis. PLoS ONE. 2017;12(5):e0177113.

Article  PubMed  PubMed Central  Google Scholar 

Ladhani SN, Collins S, Djennad A, Sheppard CL, Borrow R, Fry NK, et al. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study. Lancet Infect Dis. 2018;18(4):441–51.

Article  PubMed  Google Scholar 

Kempf M, Varon E, Lepoutre A, Gravet A, Baraduc R, Brun M, et al. Decline in antibiotic resistance and changes in the serotype distribution of Streptococcus pneumoniae isolates from children with acute otitis media; a 2001–2011 survey by the French Pneumococcal Network. Clin Microbiol Infect. 2015;21(1):35–42.

Article  CAS  PubMed  Google Scholar 

Fortanier AC, Venekamp RP, Boonacker CW, Hak E, Schilder AG, Sanders EA, et al. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev. 2014(4):CD001480. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001480.pub4/full.

Atkinson H, Wallis S, Coatesworth AP. Acute otitis media. Postgrad Med. 2015;127(4):386–90.

Article  PubMed  Google Scholar 

Littorin N, Ahl J, Uddén F, Resman F, Riesbeck K. Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county. BMC Infect Dis. 2016;16(1):407-.

Article  PubMed  PubMed Central